Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

News

Merz To Acquire ON Light Sciences

Merz North America announced plans to acquire ON Light Sciences, Inc., a US medical device company that develops technologies to enhance laser-based dermatologic procedures. ON Light Sciences’ technology includes the FDA 510(k) cleared and CE marked DeScribe Transparent PFD (perfluorodecalin) patch used during laser tattoo removal.

The DeScribe Transparent PFD Patch is placed over a tattoo prior to irradiation. This allows physicians to treat tattoos more efficiently by enabling rapid, multiple laser passes in a single treatment session. In a pilot study1, patients reported less discomfort, and faster healing post-treatment with the use of the DeScribe Transparent PFD Patch during laser tattoo removal.

“Merz North America’s robust aesthetic portfolio continues to strategically grow through innovative products addressing conditions with fast growing demand such as tattoo removal. This latest addition to our offerings underscores the strong commitment we have to growing our US business by responding quickly to market demands,” said Merz North American President and CEO Bill Humphries.

 

Reference

1. Rapid, high-fluence multi-pass q-switched laser treatment of tattoos with a transparent perfluorodecalin-infused patch: A pilot study. Biesman BS, O'Neil MP, Costner C. Lasers Surg Med. 2015 Oct;47(8):613-8. doi: 10.1002/lsm.22399.

 

Merz North America announced plans to acquire ON Light Sciences, Inc., a US medical device company that develops technologies to enhance laser-based dermatologic procedures. ON Light Sciences’ technology includes the FDA 510(k) cleared and CE marked DeScribe Transparent PFD (perfluorodecalin) patch used during laser tattoo removal.

The DeScribe Transparent PFD Patch is placed over a tattoo prior to irradiation. This allows physicians to treat tattoos more efficiently by enabling rapid, multiple laser passes in a single treatment session. In a pilot study1, patients reported less discomfort, and faster healing post-treatment with the use of the DeScribe Transparent PFD Patch during laser tattoo removal.

“Merz North America’s robust aesthetic portfolio continues to strategically grow through innovative products addressing conditions with fast growing demand such as tattoo removal. This latest addition to our offerings underscores the strong commitment we have to growing our US business by responding quickly to market demands,” said Merz North American President and CEO Bill Humphries.

 

Reference

1. Rapid, high-fluence multi-pass q-switched laser treatment of tattoos with a transparent perfluorodecalin-infused patch: A pilot study. Biesman BS, O'Neil MP, Costner C. Lasers Surg Med. 2015 Oct;47(8):613-8. doi: 10.1002/lsm.22399.

 

Merz North America announced plans to acquire ON Light Sciences, Inc., a US medical device company that develops technologies to enhance laser-based dermatologic procedures. ON Light Sciences’ technology includes the FDA 510(k) cleared and CE marked DeScribe Transparent PFD (perfluorodecalin) patch used during laser tattoo removal.

The DeScribe Transparent PFD Patch is placed over a tattoo prior to irradiation. This allows physicians to treat tattoos more efficiently by enabling rapid, multiple laser passes in a single treatment session. In a pilot study1, patients reported less discomfort, and faster healing post-treatment with the use of the DeScribe Transparent PFD Patch during laser tattoo removal.

“Merz North America’s robust aesthetic portfolio continues to strategically grow through innovative products addressing conditions with fast growing demand such as tattoo removal. This latest addition to our offerings underscores the strong commitment we have to growing our US business by responding quickly to market demands,” said Merz North American President and CEO Bill Humphries.

 

Reference

1. Rapid, high-fluence multi-pass q-switched laser treatment of tattoos with a transparent perfluorodecalin-infused patch: A pilot study. Biesman BS, O'Neil MP, Costner C. Lasers Surg Med. 2015 Oct;47(8):613-8. doi: 10.1002/lsm.22399.

 

Advertisement

Advertisement

Advertisement